Trial NCT04501978
Publication ACTIV-3 - Self WH, Lancet Infect Dis (2021) (published paper)
Dates: 2020-12-16 to 2021-03-01
Funding: Mixed (Medications provided by Vir/GlaxoSmithKline; Brii Biosciences; Gilead Sciences; US Operation Warp Speed programme, NIAID; Leidos Biomedical Research for the INSIGHT Network; NHLBI; the Research Triangle Institute for the Prevention; Early Treatment of Acute Lung Injury Network; Cardiothoracic Surgical Trials Network; the Office of Research & Development; US Department of Veterans Affairs; governments of Denmark, United Kingdom; NIH.)
Conflict of interest: Yes